Mera Pharmaceuticals, Inc.
MRPI
$0.00
$0.000.00%
| 10/31/2011 | 07/31/2011 | 04/30/2011 | 01/31/2011 | 10/31/2010 | |
|---|---|---|---|---|---|
| Net Income | -187.80K | -480.20K | -512.50K | -555.20K | -537.90K |
| Total Depreciation and Amortization | 8.30K | 11.90K | 20.90K | 26.40K | 27.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 600.00 | 314.40K | 314.40K | 314.40K | 314.40K |
| Change in Net Operating Assets | 106.90K | 14.90K | 33.10K | 223.60K | 203.90K |
| Cash from Operations | -71.90K | -138.90K | -144.00K | 9.40K | 8.50K |
| Capital Expenditure | -2.30K | -2.30K | -2.30K | -149.00K | -150.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2.30K | -2.30K | -2.30K | -149.00K | -150.00K |
| Total Debt Issued | 72.50K | 144.30K | 144.30K | 144.30K | 144.30K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 72.50K | 144.30K | 144.30K | 144.30K | 144.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.70K | 3.10K | -2.00K | 4.70K | 2.80K |
